Maternal Pre-Pregnancy Obesity Is Associated with Altered Placental Transcriptome
Maternal obesity has a major impact on pregnancy outcomes. There is growing evidence that maternal obesity has a negative influence on placental development and function, thereby adversely influencing offspring programming and health outcomes. However, the molecular mechanisms underlying these proce...
Saved in:
Published in | PloS one Vol. 12; no. 1; p. e0169223 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
26.01.2017
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Maternal obesity has a major impact on pregnancy outcomes. There is growing evidence that maternal obesity has a negative influence on placental development and function, thereby adversely influencing offspring programming and health outcomes. However, the molecular mechanisms underlying these processes are poorly understood. We analysed ten term placenta's whole transcriptomes in obese (n = 5) and normal weight women (n = 5), using the Affymetrix microarray platform. Analyses of expression data were carried out using non-parametric methods. Hierarchical clustering and principal component analysis showed a clear distinction in placental transcriptome between obese and normal weight women. We identified 72 differentially regulated genes, with most being down-regulated in obesity (n = 61). Functional analyses of the targets using DAVID and IPA confirm the dysregulation of previously identified processes and pathways in the placenta from obese women, including inflammation and immune responses, lipid metabolism, cancer pathways, and angiogenesis. In addition, we detected new molecular aspects of obesity-derived effects on the placenta, involving the glucocorticoid receptor signalling pathway and dysregulation of several genes including CCL2, FSTL3, IGFBP1, MMP12, PRG2, PRL, QSOX1, SERPINE2 and TAC3. Our global gene expression profiling approach demonstrates that maternal obesity creates a unique in utero environment that impairs the placental transcriptome. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Conceptualization: SA MTS BK SK-E CC.Data curation: SA FJE MI.Formal analysis: SA FJE SB MI JB.Funding acquisition: SA BK SK-E CC.Investigation: SA MTS SB PB CL-S SK-E.Methodology: MTS MI JB CL-S.Project administration: BK SK-E CC.Resources: JB HD CL-S BK SK-E CC.Software: SA MI JB.Supervision: SK-E CC.Validation: SB HD SK-E.Visualization: SA FJE.Writing – original draft: SA MTS.Writing – review & editing: SA MTS FJE SB PB MI JB HD CL-S BK SK-E CC. Competing Interests: Dr. Bartel reports personal fees and other form from Helmholtz Center Munich and from Research Center Borstel during the conduct of the study. Dr. Koletzko is a member of the National Breastfeeding Committee and tends to be biased towards breastfeeding. The Ludwig-Maximilians-University of Munich, Germany and its employee Dr. Koletzko has received support for scientific and educational activities by companies that market products for infants and children, including Abbott, Baxter, B. Braun, Coca Cola, Dairy Goat Cooperative, Danone, Fresenius Kabi, Fonterra, Hipp, Hochdorf, Mead Johnson, Nestlé, and Yakult, predominantly as part of publicly funded research projects with support of the European Commission or German governmental research support, outside the submitted work. The rest of the co-authors have nothing to disclose. This does not alter our adherence to PLOS ONE policies on sharing data and materials. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0169223 |